These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31453100)

  • 1. Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole.
    Ilharco M; Pereira CM; Moreira L; Proença AL; do Carmo Fevereiro M; Lampreia F; Oliveira ML; Rola J
    IDCases; 2019; 18():e00591. PubMed ID: 31453100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful long-term therapy of mucormycosis with isavuconazole.
    Brigmon MM; Ochoa B; Brust K
    Proc (Bayl Univ Med Cent); 2021; 34(6):703-704. PubMed ID: 34732994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma.
    Athanasiadou KI; Athanasiadis DI; Constantinidis J; Anastasiou A; Roilides E; Papakonstantinou E
    Med Mycol Case Rep; 2019 Sep; 25():10-14. PubMed ID: 31245270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
    Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
    Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole: A Promising Salvage Therapy for Invasive Mucormycosis.
    Shafiq M; Ali Z; Ukani R; Brewer J
    Cureus; 2018 Apr; 10(4):e2547. PubMed ID: 29963341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis: New Developments into a Persistently Devastating Infection.
    Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
    Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
    Pomorska A; Malecka A; Jaworski R; Radon-Proskura J; Hare RK; Nielsen HV; Andersen LO; Jensen HE; Arendrup MC; Irga-Jaworska N
    Mycopathologia; 2019 Feb; 184(1):81-88. PubMed ID: 30039238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
    Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of mucormycosis (zygomycosis) in the 21st century].
    Ruiz Camps I; Salavert Lletí M
    Rev Iberoam Micol; 2018; 35(4):217-221. PubMed ID: 30471896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our 2014 approach to mucormycosis.
    Tacke D; Koehler P; Markiefka B; Cornely OA
    Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
    Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
    J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital mucormycosis in an immunocompetent individual.
    Badiee P; Jafarpour Z; Alborzi A; Haddadi P; Rasuli M; Kalani M
    Iran J Microbiol; 2012 Dec; 4(4):210-4. PubMed ID: 23205254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature.
    Page RL; Schwiesow J; Hilts A
    Pharmacotherapy; 2007 Feb; 27(2):290-8. PubMed ID: 17253919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-fatal disseminated mucormycosis in a solid organ transplant].
    Minet C; Bonadona A; Tabah A; Karkas A; Mescam L; Schwebel C; Hamidfar R; Pison C; Saint-Raymond C; Faure O; Salameire D; Timsit JF
    Rev Mal Respir; 2009 Nov; 26(9):998-1002. PubMed ID: 19953048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
    Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
    Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of
    Miller RP; Farrugia L; Leask J; Khalsa K; Khanna N; Melia L
    Med Mycol Case Rep; 2021 Jun; 32():39-42. PubMed ID: 33816097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
    Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
    Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.